FoxA1 and glucocorticoid receptor crosstalk via histone H4K16 acetylation at a hormone regulated enhancer

Experimental Cell Research

Volumn 318, Issue 1, 2012, Pages 61-74

  Belikov, Sergey ^a   Holmqvist, Per Henrik ^a,b   Åstrand, Carolina ^a   Wrange, Örjan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

Chromatin presetting; FoxA1; Glucocorticoid receptor; Histone H4K16 acetylation; Steroid hormone; Xenopus oocyte

Indexed keywords

DEOXYRIBONUCLEASE I; DNA; GLUCOCORTICOID RECEPTOR; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HISTONE DEACETYLASE 4;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); DELETION MUTANT; DNA BINDING; HISTONE ACETYLATION; HYPERSENSITIVITY; IN VIVO STUDY; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TITRIMETRY; XENOPUS;

MOUSE MAMMARY TUMOR VIRUS;

EID: 81355127256     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.09.016     Document Type: Article

References (59)

1. Luger K., Mader A.W., Richmond R.K., Sargent D.F., Richmond T.J. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 1997, 389:251-260.
2. Han M., Kim U.J., Kayne P., Grunstein M. Depletion of histone H4 and nucleosomes activates the PHO5 gene in Saccharomyces cerevisiae. EMBO J. 1988, 7:2221-2228.
3. Perlmann T., Wrange Ö. Inhibition of chromatin assembly in Xenopus oocytes correlates with derepression of the mouse mammary tumor virus promoter. Mol. Cell. Biol. 1991, 11:5259-5265.
4. Pollard K.J., Samuels M.L., Crowley K.A., Hansen J.C., Peterson C.L. Functional interaction between GCN5 and polyamines: a new role for core histone acetylation. EMBO J. 1999, 18:5622-5633.
5. Payvar F., Wrange O., Carlstedt-Duke J., Okret S., Gustafsson J.A., Yamamoto K.R. Purified glucocorticoid receptors bind selectively in vitro to a cloned DNA fragment whose transcription is regulated by glucocorticoids in vivo. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:6628-6632.
6. Wilson M.D., Barbosa-Morais N.L., Schmidt D., Conboy C.M., Vanes L., Tybulewicz V.L., Fisher E.M., Tavare S., Odom D.T. Species-specific transcription in mice carrying human chromosome 21. Science 2008, 322:434-438.
7. Espinas M.L., Roux J., Pictet R., Grange T. Glucocorticoids and protein kinase A coordinately modulate transcription factor recruitment at a glucocorticoid-responsive unit. Mol. Cell. Biol. 1995, 15:5346-5354.
8. Siersbaek R., Nielsen R., John S., Sung M.H., Baek S., Loft A., Hager G.L., Mandrup S. Extensive chromatin remodelling and establishment of transcription factor 'hotspots' during early adipogenesis. EMBO J. 2011, 30:1459-1472.
9. Brownell J.E., Zhou J., Ranalli T., Kobayashi R., Edmondson D.G., Roth S.Y., Allis C.D. Tetrahymena histone acetyltransferase A: A homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 1996, 84:843-851.
10. Cairns B.R. The logic of chromatin architecture and remodelling at promoters. Nature 2009, 461:193-198.
11. Adams C.C., Workman J.L. Binding of disparate transcriptional activators to nucleosomal DNA is inherently cooperative. Mol. Cell. Biol. 1995, 15:1405-1421.
12. Belikov S., Holmqvist P.H., Astrand C., Wrange O. Nuclear factor 1 and octamer transcription factor 1 binding preset the chromatin structure of the mouse mammary tumor virus promoter for hormone induction. J. Biol. Chem. 2004, 279:49857-49867.
13. Astrand C., Belikov S., Wrange O. Histone acetylation characterizes chromatin presetting by NF1 and Oct1 and enhances glucocorticoid receptor binding to the MMTV promoter. Exp. Cell Res. 2009, 315:2604-2615.
14. John S., Sabo P.J., Thurman R.E., Sung M.H., Biddie S.C., Johnson T.A., Hager G.L., Stamatoyannopoulos J.A. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat. Genet. 2011, 43:264-268.
15. Costa R.H., Grayson D.R., Darnell J.E. Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes. Mol. Cell. Biol. 1989, 9:1415-1425.
16. Liu J.K., DiPersio C.M., Zaret K.S. Extracellular signals that regulate liver transcription factors during hepatic differentiation in vitro. Mol. Cell. Biol. 1991, 11:773-784.
17. Kaestner K.H. The FoxA factors in organogenesis and differentiation. Curr. Opin. Genet. Dev. 2010, 20:527-532.
18. Cirillo L.A., Zaret K.S. An early developmental transcription factor complex that is more stable on nucleosome core particles than on free DNA. Mol. Cell 1999, 4:961-969.
19. Cirillo L.A., Lin F.R., Cuesta I., Friedman D., Jarnik M., Zaret K.S. Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol. Cell 2002, 9:279-289.
20. Clark K.L., Halay E.D., Lai E., Burley S.K. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993, 364:412-420.
21. Pani L., Overdier D.G., Porcella A., Qian X., Lai E., Costa R.H. Hepatocyte nuclear factor 3 beta contains two transcriptional activation domains, one of which is novel and conserved with the Drosophila fork head protein. Mol. Cell. Biol. 1992, 12:3723-3732.
22. Rigaud G., Roux J., Pictet R., Grange T. In vivo footprinting of rat TAT gene: dynamic interplay between the glucocorticoid receptor and a liver-specific factor. Cell 1991, 67:977-986.
23. Nitsch D., Boshart M., Schutz G. Activation of the tyrosine aminotransferase gene is dependent on synergy between liver-specific and hormone-responsive elements. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:5479-5483.
24. Eeckhoute J., Carroll J.S., Geistlinger T.R., Torres-Arzayus M.I., Brown M. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev. 2006, 20:2513-2526.
25. Hurtado A., Holmes K.A., Ross-Innes C.S., Schmidt D., Carroll J.S. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat. Genet. 2011, 43:27-33.
26. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., Carroll J.S., Liu X.S., Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 2008, 132:958-970.
27. Wang Q., Li W., Zhang Y., Yuan X., Xu K., Yu J., Chen Z., Beroukhim R., Wang H., Lupien M., Wu T., Regan M.M., Meyer C.A., Carroll J.S., Manrai A.K., Janne O.A., Balk S.P., Mehra R., Han B., Chinnaiyan A.M., Rubin M.A., True L., Fiorentino M., Fiore C., Loda M., Kantoff P.W., Liu X.S., Brown M. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009, 138:245-256.
28. Belikov S., Gelius B., Almouzni G., Wrange Ö. Hormone activation induces nucleosome positioning in vivo. EMBO J. 2000, 19:1023-1033.
29. Richard-Foy H., Hager G.L. Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J. 1987, 6:2321-2328.
30. Zaret K.S., Yamamoto K.R. Reversible and persistent changes in chromatin structure accompany activation of a glucocorticoid-dependent enhancer element. Cell 1984, 38:29-38.
31. Holmqvist P.H., Belikov S., Zaret K.S., Wrange O. FoxA1 binding to the MMTV LTR modulates chromatin structure and transcription. Exp. Cell Res. 2005, 304:593-603.
32. Belikov S., Astrand C., Wrange O. FoxA1 binding directs chromatin structure and the functional response of a glucocorticoid receptor-regulated promoter. Mol. Cell. Biol. 2009, 29:5413-5425.
33. Brown D.D. A tribute to the Xenopus laevis oocyte and egg. J. Biol. Chem. 2004, 279:45291-45299.
34. Belikov S., Astrand C., Wrange O. Mechanism of histone H1-stimulated glucocorticoid receptor DNA binding in vivo. Mol. Cell. Biol. 2007, 27:2398-2410.
35. Almouzni G., Wolffe A.P. Replication-coupled chromatin assembly is required for repression of basal transcription in vivo. Genes Dev. 1993, 7:2033-2047.
36. Li J., Fu J., Toumazou C., Yoon H.G., Wong J. A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin. Mol. Endocrinol. 2006, 20:776-785.
37. Belikov S., Gelius B., Wrange O. Hormone-induced nucleosome positioning in the MMTV promoter is reversible. EMBO J. 2001, 20:2802-2811.
38. Buetti E., Kuhnel B. Distinct sequence elements involved in the glucocorticoid regulation of the mouse mammary tumor virus promoter identified by linker scanning mutagenesis. J. Mol. Biol. 1986, 190:379-389.
39. Cirillo L.A., McPherson C.E., Bossard P., Stevens K., Cherian S., Shim E.Y., Clark K.L., Burley S.K., Zaret K.S. Binding of the winged-helix transcription factor HNF3 to a linker histone site on the nucleosome. EMBO J. 1998, 17:244-254.
40. Zernika-Goetz M., Pines J., Ryan K., Siemering K.R., Haseloff J., Evans M.J., Gurdon J.B. An indelible lineage marker for Xenopus using a mutated green fluorescence protein. Development 1996, 122:3719-3724.
41. Belikov S., Astrand C., Holmqvist P.H., Wrange O. Chromatin-mediated restriction of nuclear factor 1/CTF binding in a repressed and hormone-activated promoter in vivo. Mol. Cell. Biol. 2004, 24:3036-3047.
42. Wrange Ö., Okret S., Radojcic M., Carlstedt-Duke J., Gustafsson J.-Å. Characterization of the purified activated glucocorticoid receptor from rat liver cytosol. J. Biol. Chem. 1984, 259:4534-4541.
43. Roux J., Pictet R., Grange T. Hepatocyte nuclear factor 3 determines the amplitude of the glucocorticoid response of the rat tyrosine aminotransferase gene. DNA Cell Biol. 1995, 14:385-396.
44. Li X., Wong J., Tsai S.Y., Tsai M.J., O'Malley B.W. Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol. Cell. Biol. 2003, 23:3763-3773.
45. Fryer C.J., Archer T.K. Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 1998, 393:88-91.
46. Ostlund Farrants A.K., Blomquist P., Kwon H., Wrange O. Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI/SNF complex. Mol. Cell. Biol. 1997, 17:895-905.
47. Vicent G.P., Nacht A.S., Font-Mateu J., Castellano G., Gaveglia L., Ballare C., Beato M. Four enzymes cooperate to displace histone H1 during the first minute of hormonal gene activation. Genes Dev. 2011, 25:845-862.
48. Corona D.F., Clapier C.R., Becker P.B., Tamkun J.W. Modulation of ISWI function by site-specific histone acetylation. EMBO Rep. 2002, 3:242-247.
49. Cai Y., Jin J., Swanson S.K., Cole M.D., Choi S.H., Florens L., Washburn M.P., Conaway J.W., Conaway R.C. Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex. J. Biol. Chem. 2010, 285:4268-4272.
50. Shogren-Knaak M., Ishii H., Sun J.M., Pazin M.J., Davie J.R., Peterson C.L. Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 2006, 311:844-847.
51. Allahverdi A., Yang R., Korolev N., Fan Y., Davey C.A., Liu C.F., Nordenskiold L. The effects of histone H4 tail acetylations on cation-induced chromatin folding and self-association. Nucleic Acids Res. 2010, 39:1680-1691.
52. Kind J., Vaquerizas J.M., Gebhardt P., Gentzel M., Luscombe N.M., Bertone P., Akhtar A. Genome-wide analysis reveals MOF as a key regulator of dosage compensation and gene expression in Drosophila. Cell 2008, 133:813-828.
53. Ruthenburg A.J., Li H., Milne T.A., Dewell S., McGinty R.K., Yuen M., Ueberheide B., Dou Y., Muir T.W., Patel D.J., Allis C.D. Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 2011, 145:692-706.
54. Bachmann P.S., Gorman R., Mackenzie K.L., Lutze-Mann L., Lock R.B. Dexamethasone resistance in B-cell precursor childhood acute lymphoblastic leukemia occurs downstream of ligand-induced nuclear translocation of the glucocorticoid receptor. Blood 2005, 105:2519-2526.
55. Egli D., Birkhoff G., Eggan K. Mediators of reprogramming: transcription factors and transitions through mitosis. Nat. Rev. Mol. Cell Biol. 2008, 9:505-516.
56. Serandour A.A., Avner S., Percevault F., Demay F., Bizot M., Lucchetti-Miganeh C., Barloy-Hubler F., Brown M., Lupien M., Metivier R., Salbert G., Eeckhoute J. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res. 2011, 21:555-565.
57. Liber D., Domaschenz R., Holmqvist P.H., Mazzarella L., Georgiou A., Leleu M., Fisher A.G., Labosky P.A., Dillon N. Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage. Cell Stem Cell 2010, 7:114-126.
58. Xu C.R., Cole P.A., Meyers D.J., Kormish J., Dent S., Zaret K.S. Chromatin "prepattern" and histone modifiers in a fate choice for liver and pancreas. Science 2011, 332:963-966.
59. Sabatino F., Masoro E.J., McMahan C.A., Kuhn R.W. Assessment of the role of the glucocorticoid system in aging processes and in the action of food restriction. J. Gerontol. 1991, 46:B171-B179.